Michele Signore

12PUBLICATIONS
46CO-AUTHORS
Molecular targetsAllergyGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 01, 2026
Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivo.

|Feb 13, 2026
Targeting Colorectal Cancer Stem Cells Through Inhibition of the Fibroblast Growth Factor Receptor 4 Pathway with a Novel Antibody.

Gessica Filocamo, Mariachiara Buccarelli, Armin Lahm

|Oct 26, 2024
Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity.

Emanuela Amore, Vittoria Cenni, Manuela Piazzi

|Oct 24, 2024
Eosinophil-airway epithelial cell crosstalk reveals the eosinophil-mediated DUOX1 upregulation in a murine allergic inflammation setting.

Carla Raggi, Francesca Spadaro, Fabrizio Mattei

|Sep 10, 2024
The dual nature of DNA damage response in obesity and bariatric surgery-induced weight loss.

David Israel Escobar Marcillo, Valeria Guglielmi, Grete Francesca Privitera

|Dec 13, 2023
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2.

Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese

Pageof 2

Frequent Collaborators

2 joint publications

Romina Alfonsi

2 joint publications

Ruggero De Maria

1 joint publications

G Simone

1 joint publications

Gerry Melino